Karrie Ka Wai Wong

Title: Karrie Ka Wai Wong: Innovator in Medical Diagnostics

Introduction

Karrie Ka Wai Wong is a notable inventor based in Toronto, Canada. She has made significant contributions to the field of medical diagnostics, particularly in the identification of CD200 levels in biological fluids. Her work has implications for diagnosing and treating medical conditions associated with elevated CD200.

Latest Patents

Karrie Wong holds a patent for an "Assay for soluble CD200." This patent discloses methods for identifying subjects with elevated CD200 levels and/or cells that overexpress CD200. The method involves assaying a biological fluid from the subject to determine the level of soluble CD200. A level above the control indicates that the subject has elevated CD200 levels. The patent also provides diagnostic methods, prognosis monitoring, and medical treatment methods related to CD200-associated medical conditions. Additionally, it includes assays and kits useful for diagnosing medical conditions associated with elevated CD200.

Career Highlights

Karrie Wong is currently associated with Trillium Therapeutics Inc., where she continues to advance her research and innovations in the medical field. Her work is pivotal in developing diagnostic tools that can significantly impact patient care.

Collaborations

Karrie collaborates with Reginald M Gorczynski, contributing to the advancement of their shared research interests and enhancing the impact of their work in the medical diagnostics arena.

Conclusion

Karrie Ka Wai Wong's contributions to medical diagnostics through her innovative patent on CD200 assays exemplify her commitment to improving healthcare outcomes. Her work continues to pave the way for advancements in the diagnosis and treatment of related medical conditions.